![Clinical Pharmacokinetics, Safety, and Tolerability of a Novel, First-in-Class TRPV4 Ion Channel Inhibitor, GSK2798745, in Healthy and Heart Failure Subjects]()
Clinical Pharmacokinetics, Safety, and Tolerability of a Novel, First-in-Class TRPV4 Ion Channel Inhibitor, GSK2798745, in Healthy and Heart Failure SubjectsGoyal, Navin; Skrdla, Pete; Schroyer, Rosemary; Kumar, Subramanya; Fernando, Disala; Oughton, Anna; Norton, Nicola; Sprecher, Dennis L.; Cheriyan, Joseph · American Journal of Cardiovascular Drugs · 2019